Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CYT009-GhrQb enters phase I/II trial for obesity

May 12, 2005

Sodium pyruvate provides neuroprotection following severe hypoglycemic shock

May 12, 2005

Amgen submits sBLA for Aranesp extended dosing

May 10, 2005

Triglide receives FDA approval

May 10, 2005

Proinflammatory adenosine A2B receptor induced in the aortic endothelium of diabetic mice

May 10, 2005

Oral-lyn launch planned this year

May 10, 2005

MC-1 shows preclinical potential for hypertriglyceridemia

May 10, 2005

LR-103 to be tested in patients with chronic kidney disease

May 10, 2005

Vav3: preclinical data identifies a potential target for the treatment of osteoporosis

May 10, 2005

Update on the efficacy of ezetimibe plus statin therapy in hypercholesterolemia

May 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...